Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2023		339,886,712
Balance at beginning of period at Dec. 31, 2023	$ 1,256,329	$ 11	$ 2,134,581	$ (65,274)	$ (812,989)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued in connection with equity awards (in shares)		3,936,518
Stock issued in connection with equity awards	23,429		23,429
Shares withheld related to net share settlement of equity awards (in shares)		(1,397,947)
Shares withheld related to net share settlement of equity awards	(80,144)		(80,144)
Repurchase of Class A common stock (in shares)		(13,466,397)
Repurchase of Class A common stock	(752,224)		(752,224)
Stock-based compensation	95,253		95,253
Other comprehensive loss, net of tax	(18,622)			(18,622)
Net income	236,183				236,183
Balance at end of period (in shares) at Mar. 31, 2024		328,958,886
Balance at end of period at Mar. 31, 2024	760,204	$ 11	1,420,895	(83,896)	(576,806)
Balance at beginning of period (in shares) at Dec. 31, 2023		339,886,712
Balance at beginning of period at Dec. 31, 2023	1,256,329	$ 11	2,134,581	(65,274)	(812,989)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	546,152
Balance at end of period (in shares) at Jun. 30, 2024		334,168,646
Balance at end of period at Jun. 30, 2024	814,836	$ 11	1,172,290	(90,628)	(266,837)
Balance at beginning of period (in shares) at Mar. 31, 2024		328,958,886
Balance at beginning of period at Mar. 31, 2024	760,204	$ 11	1,420,895	(83,896)	(576,806)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued in connection with equity awards (in shares)		9,435,913
Stock issued in connection with equity awards	9,377		9,377
Shares withheld related to net share settlement of equity awards (in shares)		(4,226,153)
Shares withheld related to net share settlement of equity awards	(356,336)		(356,336)
Stock-based compensation	98,354		98,354
Other comprehensive loss, net of tax	(6,732)			(6,732)
Net income	309,969				309,969
Balance at end of period (in shares) at Jun. 30, 2024		334,168,646
Balance at end of period at Jun. 30, 2024	814,836	$ 11	1,172,290	(90,628)	(266,837)
Balance at beginning of period (in shares) at Dec. 31, 2024		340,041,739
Balance at beginning of period at Dec. 31, 2024	1,089,818	$ 11	593,699	(103,096)	599,204
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued in connection with equity awards (in shares)		1,673,751
Stock issued in connection with equity awards	5,329		5,329
Shares withheld related to net share settlement of equity awards (in shares)		(422,322)
Shares withheld related to net share settlement of equity awards	(185,667)		(185,667)
Repurchase of Class A common stock (in shares)		(2,931,609)
Repurchase of Class A common stock	(1,001,670)				(1,001,670)
Stock-based compensation	61,281		61,281
Other comprehensive loss, net of tax	29,911			29,911
Net income	576,419				576,419
Balance at end of period (in shares) at Mar. 31, 2025		338,361,559
Balance at end of period at Mar. 31, 2025	575,421	$ 11	474,642	(73,185)	173,953
Balance at beginning of period (in shares) at Dec. 31, 2024		340,041,739
Balance at beginning of period at Dec. 31, 2024	1,089,818	$ 11	593,699	(103,096)	599,204
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,395,950
Balance at end of period (in shares) at Jun. 30, 2025		338,782,503
Balance at end of period at Jun. 30, 2025	1,167,127	$ 11	448,899	(5,149)	723,366
Balance at beginning of period (in shares) at Mar. 31, 2025		338,361,559
Balance at beginning of period at Mar. 31, 2025	575,421	$ 11	474,642	(73,185)	173,953
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued in connection with equity awards (in shares)		1,348,598
Stock issued in connection with equity awards	9,495		9,495
Shares withheld related to net share settlement of equity awards (in shares)		(195,422)
Shares withheld related to net share settlement of equity awards	(70,983)		(70,983)
Repurchase of Class A common stock (in shares)		(732,232)
Repurchase of Class A common stock	(270,118)				(270,118)
Stock-based compensation	35,745		35,745
Other comprehensive loss, net of tax	68,036			68,036
Net income	819,531				819,531
Balance at end of period (in shares) at Jun. 30, 2025		338,782,503
Balance at end of period at Jun. 30, 2025	$ 1,167,127	$ 11	$ 448,899	$ (5,149)	$ 723,366

AppLovin Corp 10-Q